Lates News

CITIC Securities research report stated that the medical beauty industry is expected to maintain steady growth in the high single digits over the next 3 years. The industry has outstanding structural opportunities, including: 1) Some medical beauty materials still have redemptive dividends such as regenerative microspheres and materials such as PDRN, ECM, silk protein, and PHA that have not yet been certified; 2) Upstream product companies with platform empowering capabilities; 3) Downstream medical beauty terminal institutions with high reputation, integrated upstream resources, and differentiated capabilities in maintaining comprehensive solutions.